James Mullen
Director/Board Member at THERMO FISHER SCIENTIFIC
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stuart R. Grant | M | 69 |
DPx Holdings BV
 DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | 3 years |
| Marc Casper | M | 55 | 23 years | |
| Gilmore O’Neill | M | 59 | 18 years | |
| Rebecca M. Holland New | M | 49 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | - |
| Susan Alexander | F | 67 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 21 years |
| John Cox | M | 61 |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 20 years |
| Michel Lagarde | M | 50 | 8 years | |
| Stelios Papadopoulos | M | 74 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 16 years |
| Harry Gill | M | 63 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | 10 years |
| Michael J. Lehmann | M | 61 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | 6 years |
| Caroline Dorsa | F | 64 | 14 years | |
| Emma Reeve | F | 63 | 3 years | |
| R. Keith | F | - | 4 years | |
| Dion Weisler | M | 56 | 7 years | |
| Eric Benjamin | M | 41 | 6 years | |
| Corinne Nevinny | F | 64 | 5 years | |
| David Scadden | M | 71 | 5 years | |
| Elliott Levy | M | 64 | 1 years | |
| Michael Boxer | M | 62 | 6 years | |
| Stephen Williamson | M | 57 | 23 years | |
| Anthony Smith | M | 62 | - | |
| Stephen Sherwin | M | 75 | 14 years | |
| Daniel Agroskin | M | 47 |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | 9 years |
| Daniel P. Shine | M | - | 26 years | |
| Bernadette Connaughton | F | 65 | 3 years | |
| Robert Perez | M | 59 |
Biomedical Sciences Careers Program, Inc.
| 23 years |
| C. Harris | M | 67 | 12 years | |
| Michael Minogue | M | 57 | 7 years | |
| Eric Rowinsky | M | 67 | 14 years | |
| Ruby Chandy | F | 62 | 2 years | |
| Debora Spar | M | 60 | 5 years | |
| George Scangos | M | 76 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
Biomedical Sciences Careers Program, Inc.
| 8 years |
| Scott Sperling | M | 66 | 18 years | |
| Lars Rebien Sørensen | M | 69 | 8 years | |
| Nelson Chai | M | 58 | 14 years | |
| Meeta Chatterjee | M | 69 | 4 years | |
| Joseph Holmes | M | 45 | 7 years | |
| Karen Nelson | M | - | - | |
| Mike Shafer | M | - | 15 years | |
| Chi Li | M | - | 3 years | |
| Gianluca Pettiti | M | 45 | 18 years | |
| Michael Dambach | M | 57 | 17 years | |
| Kate X. Zhang | M | - | 6 years | |
| Rafael Tejada | M | - | 9 years | |
| John Brian Sabo | M | 54 | - | |
| Garret Hampton | M | 58 | - | |
| Sara Nochur | M | 63 |
Biomedical Sciences Careers Program, Inc.
| - |
| Tyler Jacks | M | 63 | 15 years | |
| Lisa Britt | F | 56 | 7 years | |
| Andrew P. Slifka | M | 55 |
The Rivers School Corp.
| - |
| Corinne Broderick | F | - |
Biomedical Sciences Careers Program, Inc.
| - |
| Alan Sachs | M | - | 8 years | |
| Daniel Revers | M | 61 |
The Rivers School Corp.
| - |
| Bob J. Davis | M | 67 |
The Rivers School Corp.
| - |
| Erick Lucera | M | 57 | 1 years | |
| Mei Baisong | M | 60 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Young | M | 79 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB)
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 17 years |
| Craig Eric Schneier | M | 76 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 8 years |
| Robert W. Pangia | M | 72 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 24 years |
| William Rastetter | M | 75 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 19 years |
| Hans-Peter Hasler | M | 68 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 10 years |
| Cecil B. Pickett | M | 78 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 3 years |
| Patrick Sullivan | M | 72 | 5 years | |
| Paul Levy | M | 76 | 9 years | |
| Jim Manzi | M | 72 | 23 years | |
| Alphonse Galdes | M | 71 | - | |
| Doaa A. Fathallah | F | - | 6 years | |
| Paul Clancy | M | 62 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 16 years |
| Kevin Bitterman | M | 47 | 5 years | |
| Robert A. Hamm | M | 72 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 7 years |
| Katrine Bosley | F | 56 | 5 years | |
| Peter Kellogg | M | 67 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB)
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 7 years |
| Jim Post | M | - | 5 years | |
| Michael Lytton | M | 67 | 5 years | |
| Lynn Schenk | F | 79 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 25 years |
| Connie Matsui | F | 70 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 18 years |
| James Tobin | M | 79 | 5 years | |
| Cynthia Collins | F | 65 | 3 years | |
| Dean Frederick Wilson | M | - | 6 years | |
| Joseph Mara | M | 49 | - | |
| Alex Bruni | M | - |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | 1 years |
| Shiraz Ladiwala | M | 58 | 24 years | |
| Lynne Sullivan | F | 58 | 10 years | |
| Mark Shearman | M | 62 | - | |
| Boris Nikolic | M | 54 | 3 years | |
| Jennifer Almond | F | - | - | |
| Timothy D. Hunt | M | - | 14 years | |
| Paul M. Garofolo | M | 53 | 6 years | |
| Peter Thomas Bigelow | M | - | 1 years | |
| Nancy L. Leaming | F | 76 | 14 years | |
| Ramsey A. Frank | M | 63 | 5 years | |
| Jeffrey P. McMullen | M | 72 | - | |
| Michael MacLean | M | 58 |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | 4 years |
| Eric S. Hoffman | M | 54 | 5 years | |
| Geoffrey Glass | M | 50 | 5 years | |
| Gina Consylman | F | 52 | 3 years | |
| Regina O. Sommer | F | 66 | 9 years | |
| Alexis Borisy | M | 52 | 5 years | |
| James L. Vincent | M | 84 | 12 years | |
| Joaquín Bautista Viso | M | 81 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 90 | 90.00% |
| Canada | 13 | 13.00% |
| Netherlands | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James Mullen
- Personal Network
